Vor Biopharma Inc. (VOR) Stock: Dividends & Earnings

Company Overview:

Market Cap: $1.04B

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $6.50 - $49.64

5.7 Year VOR Performance Metrics:

Total Return (with DRIP): -97.5% (-47.49% CAGR)

Total Return (no DRIP): -97.5% (-47.49% CAGR)

Share Price: -97.5% (-47.49% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $254

Total Return $ (with DRIP): -$9,746

VOR Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

VOR Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for VOR

Based on past 5.7-year performance, here are VOR growth metrics:

Share price CAGR of -47.49%
Dividend CAGR of +0%

Using VOR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	VOR (DRIP)	VOR - No DRIP
Current Price	$19.08	$19.08
Start Shares	524.11	524.11
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	524.11	524.11
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.03	$19.08
Total Dividends	$0	$0
Final Value	$16	$10,000

Estimated Future Value + Dividends - VOR

NOTE: Above numbers are our estimate based on VOR's Dividend and Price CAGR over past 5.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Vor Biopharma Inc. (VOR) had its IPO on , and is traded on NASDAQ stock exchange.

Vor Biopharma Inc. is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its lead program is telitacicept, a dual-target fusion protein designed to regulate abnormal B-cell activity that drives autoantibody-mediated conditions. The company’s current development and commercialization efforts center on autoimmune indications such as generalized myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s disease, and IgA nephropathy. Vor Biopharma works on advancing this therapy through clinical development and broader market access, positioning its platform within the specialized immunology and biopharmaceutical segments. Headquartered in Cambridge, Massachusetts, Vor Biopharma plays a role in the market by addressing serious chronic diseases with targeted biologic treatment approaches.

VOR website: https://www.vorbio.com